2. Cheryl D. Eckard and GlaxoSmithKline plc ADR (NYSE:GSK) (2002-2010)
GlaxoSmithKline plc ADR (NYSE:GSK) whistleblower Cheryl D. Eckard allegedt that the company was manufacturing and selling adulterated pharmaceutical products. This resulted in the company paying $750 million as settlement for civil and criminal charges against it. Eckard was awarded $96 million, a record till 2010 for an individual whisteblower. And now, let’s see the number one on our list of famous corporate whistleblowers in publicly-traded companies.
Copyright: zneb076 / 123RF Stock Photo
Follow Glaxosmithkline Plc (NYSE:GSK)
Follow Glaxosmithkline Plc (NYSE:GSK)
We may use your email to send marketing emails about our services. Click here to read our privacy policy.
